Sharper Image—Do More Studies Improve Picture of Cognitive Decline?
“That's just the nature of science.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1940
ALL NEWS
378 RESULTS
You searched Esther
Sort By:
- Most Recent
- Most Commented
- Most Relevant
Autoantibodies Recognize Toxic Aβ Forms, Wane With Age, AD?
of Aβ, and that’s why they had clinical improvement,” he told ARF.—Esther Landhuis None
Chicago: Move Over, Agonists; Make Way for Modulators
Part 3. For details, see Neuroscience 2009 abstracts.—Esther Landhuis. This is Part 2 of a three-part
Chicago: New Technologies Help Drugs Cross Blood-Brain Barrier
not require MRI for targeting, and is hence less expensive, Konofagou said.—Esther Landhuis. None
Gift of the GABA? Transmitter Nixes Neurogenesis in APP, ApoE4 Mice
treatment.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2303 Alzheimer's Disease Stem
ADNI: Mission Creep From Alzheimer Disease to Healthy Senior?
Scientists don’t own their data.”—Esther Landhuis. This concludes our two-part series. See also Part 1. None
New APP Model: No Plaques—Plenty of Pathology
and Women’s Hospital, Boston, in an e-mail to ARF.—Esther Landhuis None
Research Brief: MECP2 Gene Variants Take a Piece of Your Mind
not yet been sequenced.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2221 Clinical
Research Brief: Lucky Seven—Htt N-Terminal Structure Solved
response.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2236 Triplet Repeat Diseases Huntingtin
Structure May Determine Toxicity of Huntingtin Aggregates
advanced by other scientists, as well (e.g., Chiti and Dobson, 2006).—Esther Landhuis None
APP’s Better Half? Soluble Fragment Activates Protective Genes
clearance.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2570 Alzheimer's Disease APP
ApoE2 Carriers Have Less Brain Atrophy, AD Pathology in Spinal Fluid
slower rates of mental decline, compared to people with E3 or E4 alleles.—Esther Landhuis None
ApoE and Brain Networks—The Anatomy of a Risk Factor
immunotherapy (see ARF conference story) trial data.—Esther Landhuis None
Neuroligin 1—A New Substrate for γ-Secretase
Webinar.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3296 Alzheimer's Disease α-Secretase
HAI Chicago: Can PIB Predict Cognitive Decline?
as well.—Esther Landhuis. See also Part 1 of this story. None http://www.alzforum.org/new/detail.asp?id=1806